Follistatin (FST) is required for normal embryonic and ovarian follicle development. It regulates transforming growth factor-beta superfamily ligands, being described as a ligand antagonist. It consists of a N-terminal domain with a modified TB fold ...
Follistatin (FST) is required for normal embryonic and ovarian follicle development. It regulates transforming growth factor-beta superfamily ligands, being described as a ligand antagonist. It consists of a N-terminal domain with a modified TB fold and three follistatin domains (FSD1-3) each of which is subdivided in EGF-like and Kazal-like subdomains [1-4]. This domain is important for ligand specificity.
Usually indicative of serine protease inhibitors. However, kazal-like domains are also seen in the extracellular part of agrins, which are not known to be protease inhibitors. Kazal domains often occur in tandem arrays. Small alpha+beta fold containi ...
Usually indicative of serine protease inhibitors. However, kazal-like domains are also seen in the extracellular part of agrins, which are not known to be protease inhibitors. Kazal domains often occur in tandem arrays. Small alpha+beta fold containing three disulphides.
